Horizon Europe Closed Coordination and Support Action

Pandemic preparedness and response: Maintaining and enhancing the preparatory work for a co-funded European partnership for pandemic preparedness

HORIZON-HLTH-2024-DISEASE-17-01

Description

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:

  • Investments in research and innovation on pandemic preparedness are balanced and better co-ordinated along the whole research continuum from basic research, over pre-clinical research to clinical research;
  • Research funders, policymakers and the research community dispose of an enhanced research and innovation framework for the European partnership for pandemic preparedness, including the Partnership’s objectives, governance and ways of working/operationalisation;
  • Research funders, policymakers and the research community are aligned towards common objectives and have a common understanding of the long-term Strategic Research and Innovation Agenda for the Partnership;
  • Research funders, policymakers and the research community work towards a valued network of clinical trial sites that has the capacity to implement well-coordinated large-scale multi-country quality trials in different target populations, which are able to smoothly transition to public health interventions relevant for cross-border health threats in response to a public health emergency;
  • Healthcare providers, European and international stakeholders engage with an extended number of EU-wide appropriate partners through the research and innovation framework for the partnership.

Scope:

The COVID-19 pandemic illustrated how unilateral research initiatives may lead to a fragmented research landscape, with substantial room for efficiency gains in the development of the highly needed evidence to guide policy actions when facing an emergency. A coordination and support action[1] is working towards improving the EU’s preparedness to predict and respond to emerging infectious health threats by better coordinating funding for research and innovation at EU, national (and regional) level towards common objectives and an agreed Strategic Research and Innovation Agenda. This work should be complemented by efforts towards establishing, maintaining and enhancing a network of ever-warm clinical trials sites and infrastructures for clinical research, ready to be pivoted in case of a pandemic or epidemic episode. In addition, this work should be extended to additional partners, primarily from the EU and Horizon Europe associated countries. Participation from widening countries should be ensured, promoting an inclusive approach in the design and governance of the partnership.

The partnership will contribute to building a coherent European Research Area (ERA), enabling Member States, Associated Countries and the European Commission to rapidly and jointly support research and innovation in pandemic preparedness.

The Partnership is expected to continue to build on existing pandemic preparedness networks and research infrastructures and work in synergy with the Health Emergency Preparedness and Response Authority (HERA).

Proposals should include all of the following activities:

  • Provide administrative and organisational support to prepare, ensure a smooth start and transition towards the European partnership for pandemic preparedness that will eventually take over these tasks;
  • Actively engage with relevant stakeholders and initiatives in the area of pandemic preparedness, ensuring collaboration and coordination, and avoiding duplication; e.g. the Global Health EDCTP3 Joint Undertaking, GloPID-R, WHO R&D blueprint, ACT Accelerator, etc.;
  • Implement strong communication and dissemination activities at EU level and in Member States and Associated Countries, on the purpose, activities and outputs of the European partnership for pandemic preparedness, ensuring a continuous dialogue, both outside and during epidemic/pandemic episodes;
  • As relevant, apply a cross-cutting, interdisciplinary One Health approach.

This topic requires the effective contribution of social sciences and humanities (SSH) disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities.

[1] Project BE READY / grant agreement number 101057795, funded under topic HORIZON-HLTH-2021-DISEASE-04-06 “Building a European partnership for pandemic preparedness”.

Eligibility & Scope

Eligibility Scope
EU MS
Country Restrictions
All EU/EEA countries

Water Themes

Blue Economy/Ports

Keywords

HORIZON-HLTH-2024-DISEASE-17-01, HORIZON-HLTH-2024-DISEASE-17, Bacteria, Bacteriology, Biological weapons (anthrax, botulism…), Chikingunya, Clinical data, Clinical development, Phase I, Phase II, Phase III, Clinical information, Clinical research, Clinical targets, Clinical trials, Cohort studies, Crimean Congo Haemorrhagic Fever, Dengue, Disease control, Drug development, clinical phases, late phases, Emerging Epidemics, Fungi, Helminths, Hepatitis, Infectious diseases, Influenza, Interventional clinical trials, Microbiology, Mosquito, Pathogen agents, Preparedness, Prevention and treatment of infection by pathogens (e.g. vaccination, antibiotics, fungicide), Prions, Protozoa, Public health and epidemiology, SARS, Severe acute respiratory syndrome, Smallpox, Statistics in clinical trials, Phase IV, Surveillance, Tick, Transmission, Transmission mechanism, Vector control, Veterinary medicine and infectious diseases in animals, Viral Haemorrhagic Fevers, Virology, Virulence, Viruses, West Nile, clinical trial site, epidemic, pandemic, partnership

Metadata

Programme Strand
Tackling diseases and reducing disease burden (2023/24)
Call ID
HORIZON-HLTH-2024-DISEASE-17-01
Language
EN
Last Updated
2024-11-22
Source
EC Funding & Tenders Portal (SEDIA)